NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/18/2023
Back to search
Official data from USPTO
AGMAVET
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
07/18/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/11/2017
Registration date
01/09/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/18/2023
Last transaction
07/18/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
12/27/2011
First use in commerce
12/27/2011
Drawing code
4
Owner type
01
Owner location
Henderson, NV
Examiner
HOWARD, PARKER
Law office
M80
Current location
TMO LAW OFFICE 117
Holders and representatives
Holders
G. V. (pessoa física)
G. G. (pessoa física)
Representatives
Gilad Varda
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesic and muscle relaxant pharmaceutical preparations; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-epileptic pharmaceutical preparations; Anticonvulsants; Antidepressants; Chemotherapeutics; Clinical medical reagents; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritional supplements containing agmatine; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplements; Dietary supplements also containing agmatine; Dietary supplements consisting primarily of agmatine; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for treating nerve damage; Feed supplements for pets; Food supplements; Food supplements for treating nerve damage; Gelscreams and solutions for dermatological use; Glaucoma agents; Health food supplements; Homeopathic pharmaceuticals for use in the treatment of neuropathy; Homeopathic supplements; Medicaments for promoting recovery from nerve injury; Medicated animal feed; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated skin care preparations; Medicated supplements for foodstuffs for animals; Medicinal creams for skin care; Medicinal preparations for neuropathy; Natural dietary supplements; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for the treatment of neuropathy; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for promoting nerve health; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional supplements; Nutritional supplements consisting primarily of agmatine; Nutritional supplements for promoting healthy nerves; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the form of capsules; Nutritional supplements in the nature of nutritionally fortified soft chews; Ocular pharmaceuticals; Oral analgesics; Pain relief medication; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuropathy; Pharmaceutical preparations for the treatment and prevention of neuropathy; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of neuropathy; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for neuropathy; Pharmaceutical preparationsan analgesic for human consumption taken orally; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationselixirs for the treatment of neuropathy; Pharmaceutical products for skin care for animals; Pharmaceuticalspsychotropics; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Preparation for the relief of pain; Psychotropics; Syrups for pharmaceutical purposes for the treatment of neuropathy; Therapeutic pharmaceutical for the treatment of neuropathy; Topical analgesic creams; Veterinary preparations for dog neuropathy; Veterinary preparationspain relief medication; Vitamins and dietary food supplements for animals
Publications
History of USPTO decisions and trademark events.
13 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/18/2023
E815
TEAS SECTION 8 & 15 RECEIVED
01/21/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2017
PUBO
PUBLISHED FOR OPPOSITION
10/24/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/13/2017
DOCK
ASSIGNED TO EXAMINER
09/11/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/16/2017
NWAP
NEW APPLICATION ENTERED
06/14/2017
Continuous trademark protection
Get notified about every new filing that threatens AGMAVET or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.